JP2015524464A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524464A5
JP2015524464A5 JP2015525915A JP2015525915A JP2015524464A5 JP 2015524464 A5 JP2015524464 A5 JP 2015524464A5 JP 2015525915 A JP2015525915 A JP 2015525915A JP 2015525915 A JP2015525915 A JP 2015525915A JP 2015524464 A5 JP2015524464 A5 JP 2015524464A5
Authority
JP
Japan
Prior art keywords
blood component
plasma
growth factor
gel
supernatant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015525915A
Other languages
English (en)
Japanese (ja)
Other versions
JP6339568B2 (ja
JP2015524464A (ja
Filing date
Publication date
Priority claimed from ES201200810A external-priority patent/ES2442242B1/es
Application filed filed Critical
Publication of JP2015524464A publication Critical patent/JP2015524464A/ja
Publication of JP2015524464A5 publication Critical patent/JP2015524464A5/ja
Application granted granted Critical
Publication of JP6339568B2 publication Critical patent/JP6339568B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015525915A 2012-08-09 2013-07-19 神経変性障害の治療で使用するための血漿中の成長因子を含む組成物 Expired - Fee Related JP6339568B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201200810 2012-08-09
ES201200810A ES2442242B1 (es) 2012-08-09 2012-08-09 Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
PCT/ES2013/000176 WO2014023860A1 (es) 2012-08-09 2013-07-19 Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas

Publications (3)

Publication Number Publication Date
JP2015524464A JP2015524464A (ja) 2015-08-24
JP2015524464A5 true JP2015524464A5 (enExample) 2016-07-21
JP6339568B2 JP6339568B2 (ja) 2018-06-06

Family

ID=49111229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015525915A Expired - Fee Related JP6339568B2 (ja) 2012-08-09 2013-07-19 神経変性障害の治療で使用するための血漿中の成長因子を含む組成物

Country Status (17)

Country Link
US (2) US20140044795A1 (enExample)
EP (1) EP2883569B1 (enExample)
JP (1) JP6339568B2 (enExample)
KR (1) KR102149162B1 (enExample)
CN (1) CN104519961A (enExample)
AR (1) AR092086A1 (enExample)
BR (1) BR112015002760A2 (enExample)
CA (1) CA2881075A1 (enExample)
CL (1) CL2014003510A1 (enExample)
CO (1) CO7170177A2 (enExample)
ES (2) ES2442242B1 (enExample)
IN (1) IN2014MN02675A (enExample)
MX (1) MX357828B (enExample)
PE (1) PE20150616A1 (enExample)
RU (1) RU2696497C2 (enExample)
TW (1) TWI649084B (enExample)
WO (1) WO2014023860A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2016003282A1 (es) 2016-12-21 2017-08-18 Univ Chile Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2049500A (en) * 1998-12-09 2000-06-26 Chiron Corporation Administration of neurotrophic agents to the central nervous system
AR022333A1 (es) 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo Regenerador de tejido oseo
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
ES2221770B2 (es) 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
US20070054843A1 (en) * 2005-08-26 2007-03-08 Yeomans David C Methods for treatment of headaches by administration of oxytocin
WO2008154337A1 (en) * 2007-06-08 2008-12-18 Healthpartners Research Foundation Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
ES2333498B1 (es) * 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.
KR20100075493A (ko) * 2007-09-14 2010-07-02 에스씨아이엘 테크놀로지 게엠베하 퇴행성 질환의 치료를 위한 신경내분비 인자
TWI571275B (zh) * 2009-05-14 2017-02-21 生物技術研究公司 從血液製備至少一種化合物之方法、及用於實施該方法之萃取裝置
KR101114712B1 (ko) * 2009-10-23 2012-02-29 세원셀론텍(주) 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(prp)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
ES2369945B1 (es) * 2011-07-29 2012-10-15 Eduardo Anitua Aldecoa Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento.

Similar Documents

Publication Publication Date Title
PH12019502269A1 (en) Quinazoline derivatives for the treatment of viral infections and further diseases
JP2016515522A5 (enExample)
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
WO2013151666A3 (en) Modified polynucleotides for the production of biologics and proteins associated with human disease
MX2015005947A (es) Formas de dosificacion de ruxolitinib de liberacion sostenida.
LT2726511T (lt) Kompozicijos, panaudojimai ir būdai, skirti metabolinių sutrikimų ir ligų gydymui
EA201291034A1 (ru) АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
HUE054389T2 (hu) Eljárás CFTR-mediálta betegségek kezelésére szolgáló gyógyászati kompozíciók elõállítására
EA201500365A1 (ru) Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
HUE053113T2 (hu) Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
EA201891374A1 (ru) Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение
EA201690246A1 (ru) Ингибиторы аутотаксинов, содержащие ядро гетероароматическое кольцо-бензил-амидный цикл
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
EP2797942A4 (en) COMPOSITION OF NOVEL CARBOHYDRATE MEDICINE FOR THE TREATMENT OF HUMAN DISEASES
EA201590520A1 (ru) Фармацевтическая композиция с покрытием, содержащая регорафениб
EA201692109A1 (ru) Варианты антител к фактору d и их применение
ZA202105976B (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
MX385898B (es) Moleculas de fusion derivadas de la toxina colix para suministro oral de una carga biologicamente activa.
EA201600096A1 (ru) Бензил-1н-пиразол[3,4-b]пиридины и их применение
EA201790519A1 (ru) Терапевтические соединения в качестве ингибиторов рецептора орексина-1
MX2016006604A (es) Derivados de piperidina con actividad multimodal contra el dolor.
EP3285771A4 (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa